Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the Accu-Chek® Guide, the nextgeneration blood glucose monitoring system. This new system is designed to make everyday blood glucose (BG) monitoring easier with features such as the spill-resistant SmartPack test strip vial, which helps users to remove just one strip at a time and avoid spillage or contamination.
The Accu-Chek Guide system also provides for advanced accuracy, which enables reliable diabetes management. “As the global leader in diabetes management we are dedicated to supporting people with diabetes, in thinking less about their daily therapy routines. We are very excited to introduce this innovative system, that simplifies blood glucose monitoring and improves the testing experience,” said Roland Diggelmann, CEO Roche Diagnostics.
First markets to launch the new system are Denmark, Switzerland and Australia. More countries will follow subsequently starting in early 2017.
The Accu-Chek Guide system enables on-board pattern detection that helps to increase awareness of too high or too low glucose readings as well as Bluetooth Low Energy connectivity to the Accu-Chek Connect diabetes management solution via a mobile app.
This cloud-based solution guarantees a secure online data exchange and automatic data logging. People with diabetes, caregivers, and healthcare providers can share diabetes information virtually anywhere for timely advice and remote monitoring.
…97% of 197 participants in a recently published study from France and the US agreed that the system was very easy to use and offers a better testing experience…
Such telemedicine solutions can help people with diabetes and their caregivers manage diabetes more efficiently and give them peace of mind and a feeling of relief.
Hence, 97% of 197 participants in a recently published study from France and the US agreed that the system was very easy to use and offers a better testing experience (Ref. 1).
The Accu-Chek Guide system not only fulfills current accuracy standards (Ref. 2) but delivers even tighter 10/10 accuracy for more reliable results (Ref. 3).
Consistently accurate measurements are essential for reliable BG monitoring and deriving the correct therapy decisions (Ref. 4,5). Large deviations of the measured BG values from the true glucose levels can result in higher HbA1c levels, glycemic excursions and markedly increased rates of hypoglycemic events, as a recently published retrospective study revealed (Ref. 6).
In addition, studies have demonstrated that only about half of the BG meters evaluated meet the minimum accuracy requirements as defined by the ISO 15197:2013/EN ISO 15197:2015 standard (Ref. 7,8).
1 Harvey C., et al., J Diabetes Sci Technol July 2016; Published online before print July 6, 2016, DOI: 10.1177/1932296816658058
2 International Organization for Standardization (ISO). ISO 15197:2013. http://www.iso.org/iso/catalogue_detail?csnumber=54976
3 Brazg R., et al. J Diabetes Sci Technol June 2016; Published online before print June 5, DOI: 10.1177/1932296816652902
4 Brazg R., et al. J Diabetes Sci Technol 2013;7:144-152
5 Ginsberg B., J Diabetes Sci Technol. Jul 2009;3(4):903-913
6 Boettcher, C. et al., Diabetes Technol Ther. Apr 2015;17(4):275-282
7 Freckmann G,et al., J Diabetes Sci Technol. Sep 2012;6(5):1060-1075
8 Baumstark A, et al., J Diabetes Sci Technol. Sep 2012;6(5):1076-1086